Company Overview of Osel Inc.
Osel Inc., a clinical stage biopharmaceutical company, develops proprietary technology platform of live biotherapeutic products for the treatment and prevention of conditions impacting women’s health, gastrointestinal disorders, and infectious diseases through modulation of the Human Microbiome. It provides LACTIN-V, a safety profile and is accepted and tolerated by the study populations; MIYA-BM, an orally-administered LBP that is based on a bacterial strain safely; and MucoCept, which involves the use of proprietary technology designed to harness the Human Microbiome. The company was founded in 1996 and is based in Mountain View, California.
320 Logue Avenue
Mountain View, CA 94043
Founded in 1996
Key Executives for Osel Inc.
Similar Private Companies By Industry
|Trius Therapeutics, Inc.||United States|
|Novartis Animal Vaccines, Inc||United States|
|Mellitus, LLC||United States|
|North American Bioproducts Corporation||United States|
|Hyprocell LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Osel Inc., please visit www.oselinc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.